Help to stop smoking

Tag: quit smoking

  • Laryngeal cancer

    Laryngeal cancer

    Laryngeal cancer affects the voice box and is most often caused by smoking and heavy alcohol use. Persistent hoarseness is the most common early sign, along with throat discomfort or difficulty swallowing. When detected early, the disease is highly treatable and survival rates are high; outcomes are poorer when diagnosis is delayed. Prevention through avoiding tobacco and excessive alcohol, and prompt medical attention for lasting voice changes, are key to saving lives.

    Laryngeal cancer affects a vital organ: the larynx, often called the voice box. Located at the top of the windpipe, the larynx plays a central role in breathing, speaking, and swallowing. When cancer develops there, it can profoundly alter daily life, sometimes in ways that are both visible and audible.

    Laryngeal cancer is far more common in men than in women, a difference that largely reflects patterns of tobacco and alcohol use. The disease is usually diagnosed after the age of 50, though cases in younger people are not unheard of.

    The causes of laryngeal cancer are well established. Tobacco is by far the leading risk factor. Cigarettes, cigars, pipes, and even some smokeless tobacco products expose the lining of the larynx to carcinogenic substances that, over time, can trigger malignant changes. Alcohol acts as a powerful accomplice: heavy drinking combined with smoking multiplies the risk. Other factors can also play a role, including occupational exposure to certain chemicals, such as asbestos or wood dust. Infection with the human papillomavirus, better known for its link to cervical cancer, has also been implicated in a subset of cases.

    Because the main causes are known, prevention is straightforward. Avoiding tobacco dramatically reduces the risk, and the benefits begin soon after quitting. Limiting alcohol consumption adds further protection. Workplace safety measures that reduce exposure to harmful fumes and dusts matter as well.

    The first signs of the disease are often subtle, which explains why diagnosis can be delayed. Persistent hoarseness is the most common warning sign, especially when it lasts longer than a few weeks and has no obvious cause. A sore throat that does not go away, difficulty or pain when swallowing, a sensation of a lump in the throat, chronic cough, or ear pain can also be clues. In more advanced stages, breathing may become difficult, or a mass may be felt in the neck due to spread to nearby lymph nodes.

    When such symptoms raise suspicion, diagnosis usually begins with a careful examination of the throat by an ear, nose, and throat specialist. Using a small camera passed through the nose or mouth, the doctor can visualize the larynx directly. If an abnormal area is seen, a biopsy is required to confirm the presence of cancer. Imaging tests such as CT scans, MRI, or PET scans help determine how far the disease has spread, information that is crucial for choosing the best treatment.

    The course of laryngeal cancer varies widely. Tumors confined to the vocal cords tend to be detected earlier, because even small lesions can affect the voice. These early-stage cancers generally have an excellent prognosis. Cancers that arise above or below the vocal cords may grow larger before causing symptoms and are therefore more often diagnosed at a later stage. Over time, untreated cancer can invade nearby tissues or spread to lymph nodes and distant organs, making treatment more complex and outcomes less favorable.

    Treatment depends on the stage of the disease, the exact location of the tumor, and the patient’s overall health. For early cancers, radiation therapy or limited surgery can often eliminate the tumor while preserving the voice. More advanced cases may require a combination of surgery, radiotherapy, and chemotherapy. In some situations, part or all of the larynx must be removed to control the disease, a life-saving operation that has profound consequences for speech and breathing. Advances in reconstructive surgery, voice rehabilitation, and assistive technologies have greatly improved quality of life for people who undergo such procedures.

    Survival rates reflect this wide spectrum of disease. When laryngeal cancer is diagnosed at an early stage, five-year survival can exceed 80 or even 90 percent. For cancers detected later, especially those that have spread beyond the larynx, survival drops significantly, often to around 40 percent or less. These figures underscore a simple but crucial message: early detection saves lives.

    Laryngeal cancer is a disease in which prevention, awareness of symptoms, and timely medical attention make a tangible difference.

    Use the ‘Comments’ field below to share your experience with larynx cancer or to suggest improvements to this article.

  • Cognitive Behavioral Therapy (CBT)

    Cognitive Behavioral Therapy (CBT)

    Quitting smoking is best done with the support of a therapist. While nicotine replacement therapies and medications often play a role, a powerful non-pharmacological tool is increasingly being recognized for its effectiveness: Cognitive Behavioral Therapy (CBT).

    CBT, at its core, is a structured, goal-oriented approach to psychological treatment. But when applied to smoking cessation, it becomes a sophisticated strategy designed to dismantle the mental machinery that keeps the habit alive.

    The Core Idea: Thoughts, Feelings, and Actions

    CBT operates on the principle that our thoughts, feelings, and actions are interconnected. In the context of smoking, the act of lighting up isn’t just a physical craving; it’s often the final step in a chain of automatic thoughts and emotional responses.

    For example, a stressful day at work might trigger the thought, “A cigarette will calm me down.” This thought leads to feelings of anxiety relief and, finally, the action of smoking. CBT aims to break this chain by identifying and modifying the unhelpful thoughts and behaviors that serve as “triggers.”

    How a Session Unfolds

    CBT for smoking cessation is typically delivered over several sessions, either individually or in a group setting. It is not a casual chat; it involves active work and strategy building.

    First, the therapist and patient establish a precise functional analysis of the smoking habit. This means meticulously tracking when, where, and why the person smokes. It seeks to answer the crucial question: what function does the cigarette actually serve? Is it a social crutch, a mechanism for managing stress, or a way to fight boredom?

    Once these triggers are mapped out, the core techniques of CBT come into play:

    Cognitive Restructuring: This involves challenging and replacing the nicotine-related beliefs that have been ingrained over years. For instance, the thought “I can’t handle stress without a cigarette” is challenged with evidence and alternative, more constructive coping statements, such as “I can manage stress by taking a short walk or using deep breathing.”

    Behavioral Skills Training: Patients are taught concrete strategies to avoid and cope with high-risk situations. This includes stimulus control—changing environmental cues that trigger smoking (like moving an armchair where they always smoked)—and coping skills training, which equips them with alternatives to smoking when a craving hits. This might be a physical activity, a relaxation technique, or a simple distraction method.

    Relapse Prevention: This is a crucial final phase. It prepares the individual for inevitable slip-ups or cravings by viewing them not as failures, but as temporary setbacks that can be learned from. Patients develop a tailored “escape plan” for high-risk situations in the future.

    Who Benefits and Who Should Be Cautious?

    CBT has demonstrated significant effectiveness, particularly when combined with pharmacological aids like Varenicline or Nicotine Replacement Therapy (NRT). Studies show that by addressing both the physical addiction and the psychological dependence, the chances of sustained abstinence are substantially higher.

    It is highly suitable for:

    • Individuals with strong psychological dependence: Those whose smoking is heavily tied to emotional states, stress, or specific environments.
    • Smokers with co-occurring anxiety or depression: CBT is often a first-line treatment for these conditions, making it a powerful dual-purpose tool.
    • Those who have tried other methods and relapsed: CBT offers a fresh approach by focusing on the underlying thought patterns that led to the return of the habit.

    It may be less suitable for:

    • Individuals unwilling to engage in introspection: CBT requires motivation and a willingness to examine one’s own thoughts and challenge long-held beliefs. It is an active process that requires homework and commitment.

    Rate this article by clicking on the desired number of stars:
    1 Star2 Stars3 Stars4 Stars5 Stars (1 votes, average: 5.00 out of 5)
    Loading...

    Please use the “Comments” field below to share your experience or suggest improvements to this article.

  • Body Mass Index

    Body Mass Index

    Calculate your body mass index (BMI) using the calculator below to find out if you are overweight or obese. We also provide a brief but comprehensive and scientifically based explanation of the advantages and limitations of BMI below:

    Easily calculate your BMI:

    Body mass index (BMI) is a simple measure that takes into account your height and weight to determine whether you are at a healthy weight. Although this measure is not perfect, it can be useful for setting a goal (e.g., achieving a BMI of 24.9). The BMI score is calculated by dividing your weight in kilograms by the square of your height in meters, so the result is given in kg/m2. For example, a person weighing 70 kg and measuring 1.65 m tall has a BMI of 25.7.

    So, on the calculator, you would type: 70 / 1.65 / 1.65.

    Interpretation of results: BMI (in kg/m2):.

    • less than 18.5: underweight
    • 18.5 to 24.9: healthy weight
    • 25 to 29.9: overweight
    • 30 to 34.9: moderate obesity (class I)
    • 35 to 39.9: severe obesity (class II)
    • 40 and above: morbid obesity (class III)

    Limitations of BMI:

    BMI is not a perfect indicator of body fat, particularly in very muscular individuals, and it does not take skeletal mass into account. Furthermore, BMI is not linearly associated with disease risk or mortality. In fact, it is mainly the amount of abdominal fat that determines cardiovascular risk, rather than the total amount of fat. It is therefore advisable to also measure your waist circumference, which gives a good estimate of abdominal fat mass.

    BMI is an old measurement. It was proposed in the 19th century and was first used by insurers to estimate mortality risk. It is therefore primarily a descriptive index, but one that is currently used in a prescriptive manner. This becomes problematic when BMI is used to determine who can access drugs such as Ozempic or who can obtain reimbursement for them. Other methods should therefore be used, such as the Edmonton classification of obesity stages,(a) which uses several indicators to determine whether a person is obese. Ideally, direct measurements of body fat should be used.(b)

    You can also purchase a bathroom scale that uses an electrical induction system to indicate your weight, body fat, and muscle mass (price: starting at 25 USD or UK£).

    Also, you can measure your waist circumference, which is a good indicator of your amount of abdominal fat (and therefore your cardiovascular risk).

    Please rate this article by clicking on the desired number of stars:
    1 Star2 Stars3 Stars4 Stars5 Stars (1 votes, average: 5.00 out of 5)
    Loading...

    Use the Comment field below to share your experience with BMI and suggest improvements to this article, or write a testimonial about it.

    If you like this page, please mention it in a post on social media or link to it on your website. Thank you.

    References:

    a) Canning KL, Brown RE, Wharton S, Sharma AM, Kuk JL. Edmonton Obesity Staging System Prevalence and Association with Weight Loss in a Publicly Funded Referral-Based Obesity Clinic. J Obes. 2015;2015:619734. doi: 10.1155/2015/619734. (Lien).

    b) A. M. Prentice, S. A. Jebb. Beyond body mass index. Obesity Reviews. Volume 2, Issue 3, August 2001, Pages 141-147. (Lien). https://doi.org/10.1046/j.1467-789x.2001.00031.x

  • Measuring waist circumference

    Measuring waist circumference

    Measuring your waist circumference provides a quick and easy assessment of your abdominal fat, which is a good indicator of your risk of developing health problems such as diabetes, cardiovascular disease and high blood pressure. Here is how to measure your waist circumference and interpret the result:

    Check your measurement and your health risk:

    Body fat is distributed in two ways: under the skin and in the abdomen. It is mainly abdominal fat that is associated with a higher risk of disease and mortality. Measuring your waist circumference provides a simple, inexpensive, and reliable estimate of your amount of abdominal fat.

    Here’s how to measure your waist circumference:

    • Get a flexible measuring tape (sewing tape measure), then locate the top of your iliac crest (the protruding bone on the side where your belt rests) on each side.
    • Stand up straight with your heels and toes touching the floor and breathe normally.
    • Wrap the tape around your waist, at the level of your two iliac crests and your navel, directly on the skin.
    • Make sure the tape is snug, not too tight, and that it forms a ring parallel to the floor.
    • Take the measurement after exhaling (= emptying your lungs). Write down the measurement and the date.

    Here is how to interpret the measurement result:

    Based on guidelines from organizations such as the World Health Organization (WHO) and various health agencies, here are the generally accepted thresholds for high risks and very high risks associated with waist circumference in adults:

    Waist circumference risk thresholds (PDF):

    SexRisk LevelWaist: cmWaist: Inches
    WomenHigh Risk≥ 80 cm≥ 31.5 in
    Very High Risk≥ 88 cm≥ 35 in
    MenHigh Risk≥ 94 cm≥ 37 in
    Very High Risk≥ 102 cm≥ 40 in

    Waist size and health consequences:

    If your waist circumference is greater than 94 cm / 37 in (men) or 80 cm / 31.5 in (women), this may indicate that you have excess abdominal fat. In this case, a change in lifestyle is recommended (eating better and exercising more), or medical treatment for overweight or obesity may be warranted.(a) Note that even if your body mass index (BMI) is within the normal range (below 25 kg/m²), your cardiovascular risk is increased if your waist circumference exceeds the above values.

    A waist circumference greater than 102 cm / 40 in for men and 88 cm / 35 in for women is one of the diagnostic criteria for metabolic syndrome. This syndrome includes several factors associated with an increased risk of cardiovascular disease, including: high blood cholesterol, sugar, and insulin levels, high blood pressure, inflammation, etc.

    A large waist circumference is also strongly associated with the risk of developing type 2 diabetes, even more so than body mass index (BMI).(a) A large waist circumference is also strongly associated with the risk of cardiovascular mortality, as well as the risk of death from all causes.(a)

    How to lose weight?

    By reducing your waist circumference, you increase your chances of avoiding diabetes, cardiovascular disease, or premature death.
    – Follow our advice for losing weight,
    – Consult a professional who may be able to prescribe treatment,
    – Get support.

    Please note:
    It is strongly discouraged to lose weight if you are underweight, i.e., if, as an adult, your BMI is less than 18.5 kg/m2.

    Please rate this article by clicking on the desired number of stars:
    1 Star2 Stars3 Stars4 Stars5 Stars (1 votes, average: 5.00 out of 5)
    Loading...

    => Also calculate your body mass index (BMI).

    Use the ‘Comments’ field below to share your experience and suggest improvements to this article, or write a testimonial about it. If you liked this article, please share it on social media or on your website.

    Reference:

    a) Ness-Abramof, R. and Apovian, C.M. (2008), Waist Circumference Measurement in Clinical Practice. Nutr Clin Pract, 23: 397-404. https://doi.org/10.1177/0884533608321700

  • Bupropion (Zyban)

    Bupropion (Zyban)

    When it comes to quitting smoking, nicotine replacement therapies are not the only option available. For some smokers, particularly those who struggle with the psychological aspects of withdrawal, a medication alternative called bupropion, marketed under the name Zyban, can prove decisive.

    Bupropion is not a nicotine substitute; it is an atypical antidepressant serendipitously discovered to be effective in smoking cessation. Its mechanism of action relies on modifying the levels of certain neurotransmitters in the brain, notably dopamine and norepinephrine. By acting on these chemical substances, Bupropion manages to reduce the intensity of the urge to smoke and alleviate the unpleasant symptoms of withdrawal, such as irritability, anxiety or depressed mood, which are often major factors leading to relapse.

    Treatment Protocol and Dosage

    Treatment with Bupropion is a commitment that generally lasts seven to nine weeks. It is crucial that the patient starts taking the medication one to two weeks before their set quit date. This preparation phase is essential to allow Bupropion to reach an optimal therapeutic concentration in the blood before complete cessation is initiated.

    The usual dosage starts with one 150 mg tablet once daily for the first six days. From the seventh day, the dose is typically increased to 150 mg twice daily, ensuring that doses are spaced at least eight hours apart. It is imperative not to exceed 300 mg per day. This gradual increase is necessary to ensure maximum efficacy and to minimize side effects. The importance of a sufficient dose is central: if the smoker continues to feel a strong urge to smoke or significant withdrawal symptoms, it means the treatment is not fully effective, requiring careful medical monitoring to ensure the dosage is adequate and adhered to.

    Experts emphasize the importance of never stopping treatment prematurely. Even after successfully quitting smoking, it is recommended to continue the therapy until the end of the prescribed cycle to consolidate cessation and prevent the risk of relapse, which is particularly high in the first few weeks.

    For the user, the main recommendation is to strictly follow the doctor’s instructions, especially the timing of quitting smoking during the course of treatment. It is essential not to take a double dose if one is missed and to immediately inform the doctor of any changes in behavior or mood.

    Efficacy and Profile of Beneficiaries

    Clinical studies have shown that Bupropion roughly doubles the success rate of cessation compared to a placebo. Its efficacy is comparable to nicotine replacement therapy and is enhanced when combined with behavioral support.

    Bupropion is particularly beneficial for a specific category of smokers: those with a history of mood disorders, especially depression. Since it has antidepressant activity, it helps not only with quitting smoking but also with preventing the onset or worsening of depressive symptoms that may occur during withdrawal.

    If you feel depressed or have suicidal thoughts, consult your doctor immediately or go to the nearest hospital.

    Side Effects and Contraindications

    Like any medicinal treatment, Bupropion has side effects and strict contraindications. The most common side effects include dry mouth and, very frequently, insomnia, which is why the second daily dose should be taken in the early afternoon, far from bedtime.

    The most severe contraindication concerns seizure disorders or any factor that lowers the seizure threshold (such as a head injury or alcohol abuse), as Bupropion slightly increases the risk of seizures. It is also strictly contraindicated in cases of eating disorders (anorexia or bulimia) or during abrupt alcohol or benzodiazepine withdrawal. A thorough medical examination is therefore essential before any prescription.

    Serotonin syndrome (a potentially life-threatening condition) may occur, particularly when bupropion is taken in excessive doses or in combination with medications that affect serotonin levels.

    Pregnancy, Breastfeeding, and User Recommendations

    Regarding pregnancy and breastfeeding, Bupropion is generally not recommended. In the absence of robust safety data and considering potential risks to the fetus or infant, the first line of treatment for pregnant women remains the use of Nicotine Replacement Therapies, always under close medical supervision, or cessation without medicinal aid.

    Use the “Comments” field below to share your experience with bupropion or to suggest improvements to this page.

  • IQOS

    IQOS

    Here is a summary about IQOS: what it is, how it works, the difference between combustion and pyrolysis, the composition of the aerosol compared to cigarette smoke, nicotine exposure: amount and speed of absorption into the blood and brain, can it help smokers quit, impact on cigarette sales in Japan, who should and should not use it, the fact that the US FDA has authorized it as a reduced exposure product but not as a reduced risk product, does it reduce health risks compared to cigarettes, impact on PMI’s sales and profits, the problem of the scarcity of manufacturer-independent research, and the controversy surrounding tobacco harm reduction. Use a journalistic style without bullet points or numbered lists, and avoid words, phrases, and transitional sentences typical of AI-generated content.

    IQOS, the flagship heated tobacco product from Philip Morris International (PMI), has become a fixture in the global debate over smoking and public health. Marketed as a revolutionary alternative to cigarettes, the device and its success, particularly in Japan, represent a high-stakes experiment in the contentious world of tobacco harm reduction.

    How Heating Differs from Burning

    At its core, IQOS is an electronic device designed to heat specially prepared tobacco sticks, called HEETS or HeatSticks, to a precise temperature, typically around 350 °C. This is the crucial distinction from a conventional cigarette, which combusts tobacco at temperatures often exceeding 800 °C.

    The difference lies in the process: Cigarettes rely on combustion (burning), which generates smoke filled with complex byproducts, including solid particles and toxic chemicals.5 IQOS employs a process closer to pyrolysis (thermal decomposition in the absence of oxygen). This heating process generates an aerosol—a vapor composed primarily of nicotine and water, rather than smoke.6

    What’s In the Cloud: Aerosol Composition

    Because it avoids combustion, the aerosol produced by IQOS contains significantly lower levels of many harmful and potentially harmful chemical constituents compared to cigarette smoke.7 Manufacturer-sponsored studies often claim reductions of 90-95% for certain key toxicants, excluding nicotine.8 However, independent research has noted that while levels of many harmful substances are indeed reduced, the aerosol still contains nicotine and measurable concentrations of some toxicants, and the full long-term health impact is not yet known.9 Some independent analyses have even noted that certain chemicals may be present in higher concentrations compared to traditional smoke.10

    Nicotine Delivery and Addiction

    The device is specifically engineered to ensure that the user receives an amount and rate of nicotine absorption comparable to smoking a conventional cigarette.11 While the nicotine content in the specific tobacco sticks might be lower than in a cigarette, the delivery mechanism is highly efficient.12 This rapid and substantial dose of nicotine is what makes the product satisfying to current smokers, but it also ensures the user remains exposed to and dependent on an addictive substance.13 The amount of nicotine absorbed is similar to a cigarette, establishing a theoretical one-to-one usage ratio.14

    The Japan Experiment: Impact on Cigarette Sales

    Japan has become the key real-world laboratory for heated tobacco products.15 Following the widespread introduction of IQOS in 2014-2015, independent studies noted a dramatic, accelerated decline in sales of traditional cigarettes.16 Where cigarette sales were already falling slowly, the decline accelerated significantly, suggesting that a large number of smokers in Japan made a complete switch to the heated product.17 The experience there is frequently cited as proof that heated tobacco products can displace cigarette are are an alternative to them. Smoking rates among the general japanese population may not change as a result, as IQOS users may continue to smoke a few cigarettes.

    The Regulatory Status: Reduced Exposure, Not Reduced Risk

    In the United States, the Food and Drug Administration (FDA) authorized IQOS for marketing with a reduced exposure claim in 2020. This allows the company to communicate that “Scientific studies have shown that switching completely from conventional cigarettes to the IQOS system significantly reduces your body’s exposure to harmful or potentially harmful chemicals.”18

    Crucially, the FDA explicitly stated that this authorization did not mean IQOS had been proven to reduce the risk of disease or harm.19 The agency found that the evidence did not yet support a reduced risk claim, meaning users cannot assume that switching guarantees an improvement in long-term health outcomes compared to continued smoking, though the exposure is lower.

    Who Should Use It?

    IQOS is not a smoking cessation product; it is a tobacco product. Health authorities and the manufacturer agree that the product is intended only for adult smokers who would otherwise continue to smoke.20 It should not be used by non-smokers, former smokers, or young people, as it delivers addictive nicotine and carries health risks.21 Whether it genuinely helps smokers quit completely, rather than merely switching products, remains a subject of ongoing debate and research.

    The Conflict of Research and Profit

    The majority of the data initially supporting IQOS’s reduced-exposure claims came from PMI-sponsored studies, leading to persistent concerns within the public health community about the scarcity of fully manufacturer-independent research. While the number of independent studies is growing, there remains a lack of long-term data on health outcomes.22

    The controversy is central to the broader tobacco harm reduction debate.23 Advocates argue that providing a significantly less harmful nicotine delivery system offers smokers who are unwilling or unable to quit an invaluable path away from deadly cigarettes.24 Critics fear that these products, while potentially less harmful than smoking, risk addicting a new generation of users, undermine decades of successful tobacco control efforts, and serve primarily to boost the profits of tobacco companies like PMI, whose market share and revenue have significantly benefited from the global uptake of IQOS.

    The verdict on whether heated tobacco products serve the overall public health interest will not be rendered by initial sales figures or regulatory labels, but by decades of independent research tracking population health outcomes.

    Use the Comments field below to share your experience with IQOS or to suggest improvements to this article.

  • Women’s health and smoking

    Women’s health and smoking

    In this section, you will find information on the specific health issues faced by women who smoke:

  • 10 policies against smoking

    10 policies against smoking

    Smoking remains a scourge on public health and a major factor of healthcare costs, but the good news is that governments worldwide have effective and proven tools at their disposal to combat it. This article presents the ten most effective policy measures, backed by scientific evidence, that can significantly reduce smoking and save lives.

    These policies work by either making smoking less appealing and accessible, or by empowering smokers to quit.

    The Economic Approach: Making Tobacco Unaffordable

    1. Raise Taxes on Tobacco Products

    This is widely considered the single most effective policy for reducing tobacco consumption. Significant and regular increases in excise taxes make tobacco products less affordable, discouraging young people from starting and incentivizing current users to quit. For every 10% price increase, studies show a significant reduction in overall consumption, with the greatest impact seen among youth and low-income populations.

    2. Eliminate Tax-Free and Duty-Free Sales

    By removing tax exemptions for tobacco sold at airports and border crossings, governments close a loophole that allows products to be sold at artificially low prices. This policy maintains the price disincentive and prevents cheap tobacco from undermining local taxation efforts.

    Clean Air and Social Norms: Protecting the Public

    3. Implement Comprehensive Smoke-Free Laws

    Laws mandating 100% smoke-free indoor public places, workplaces, restaurants, and bars protect non-smokers from the harms of secondhand smoke. Furthermore, these policies change social norms, making smoking less visible, less socially acceptable, and providing a powerful incentive for smokers to quit. Well-enforced bans have been shown to reduce smoking prevalence itself.

    Extending smoke-free regulations to include outdoor areas—such as parks, beaches, school grounds, and hospital entrances—further de-normalizes smoking, protects children from exposure, and reinforces the public health message that smoking is not a typical behaviour.

    Replace combustible products with smokefree products

    4. Accelerate the replacement of cigarettes with non-combustible products

    The tobacco market is undergoing rapid change, with cigarettes becoming an obsolete and inferior product, replaced by non-combustible alternatives.

    It is essential to accelerate the transition of smokers to these new products, while implementing effective and proportionate policies to prevent young non-smokers from starting to use nicotine or tobacco.

    5. Providing truthful information and combating disinformation

    Misinformation about harm reduction and non-combustible nicotine and tobacco products is ubiquitous. Governments should support the creation and dissemination of truthful, balanced, and honest information on these topics.

    Stopping the Next Generation: Eliminating Promotion and Appeal

    6. Enforce Comprehensive Bans on Tobacco Advertising, Promotion, and Sponsorship (TAPS)8

    Tobacco advertising recruits new users and undermines quit attempts. A total ban on all forms of TAPS—including in traditional media, online, at the point of sale, and through product placement or sponsorship—is highly effective at reducing tobacco initiation, particularly among youth.9

    7. Mandate Graphic Health Warnings and Plain Packaging

    Removing all branding, colours, and promotional elements from tobacco packaging (plain packaging) and requiring large, graphic health warnings that cover at least 50% (and ideally much more) of the pack surface reduces the product’s appeal and increases consumer awareness of the harms.10 This policy eliminates the pack as a marketing tool.11

    Empowerment and Support: Helping People Quit

    8. Provide Accessible and Affordable Smoking Cessation Services

    While policies reduce demand, many addicted smokers need help to quit.15 Governments must invest in comprehensive cessation support, including:

    • Toll-free national quitlines.
    • Coverage for proven therapies (like NRT and prescription medicines such as varenicline and cytisine) and behavioral counselling through national health insurance programs.16
    • Integrating ‘Ask, Advise, Refer’ protocols into routine healthcare.17

    9. Run Sustained, High-Impact Mass Media Campaigns

    Hard-hitting, professionally produced anti-tobacco media campaigns that clearly communicate the health risks and benefits of quitting are highly effective.18 These campaigns should be sustained over time and run at high frequency to ensure maximum reach and impact, reinforcing the message that help is available.

    Monitor tobacco use and evaluate interventions

    10. Monitor tobacco use and evaluate campaigns and policies

    It is crucial to monitor tobacco and nicotine use in each population subgroup, and to assess the intended and unintended effect of all interventions, campaigns, policies, treatments and other anti-tobacco measures.

    Use the ‘Comments’ field below to share your experience or to suggest improvements to this article.

  • Health benefits of quitting smoking

    Health benefits of quitting smoking

    Quitting smoking is one of the single most important steps you can take to improve your health, regardless of your age or how long you’ve smoked. The benefits begin almost immediately and continue to increase over time. Here’s what you need to know about the benefits of quitting smoking, its effects on symptoms and health after 1 day, 1 week, 1 month, 1 year, and 10 years, including specific benefits for women and older smokers.

    Time After QuittingHealth Outcome/Symptom Effect
    20 MinutesCarbon monoxide level in your blood decrease already
    12 HoursThe carbon monoxide level in your blood drops to normal, increasing the oxygen in your blood.
    1 Day– Your risk of a heart attack begins to decrease.
    – Blood pressure continues to drop.
    – You have better breath (less odor) and you no longer smell like cold smoke.
    2-3 Days– Your sense of taste and smell improves.
    – Bronchial tubes start to clean, making breathing easier.
    – You already spared enough money to buy a book.
    1 Week– Energy levels increase.
    – You cough and expectorate less.
    2 Weeks to 3 Months– Circulation improves, and lung function increases (by up to 30% in some cases).
    – Walking and physical activity become easier.
    1 to 9 Months– Coughing and shortness of breath decrease as the cilia (tiny hairs that clean the lungs) regain normal function, offering a better protection against infectious agents.
    – The risk of respiratory infection decreases
    – Sinus congestion and lung capacity continue to improve.
    1 Year– Your risk of coronary heart disease (heart attack) is half that of a smoker.
    – You have already saved enough money to treat yourself to two weeks of your dream vacation.
    5 Years– Your risk of stroke is reduced to that of a non-smoker.
    – Your risk of mouth, throat, and esophageal cancer is cut in half.
    10 Years– Your risk of dying from lung cancer is about half that of a person who is still smoking.
    – Your risk of bladder, kidney, and pancreatic cancers also decreases.
    – You saved enough money to by a new car
    15 Years– Your risk of coronary heart disease is nearly the same as that of a non-smoker.
    – Your risk of dying from almost any cause is almost the same as that of a non-smoker.

    Immediate & Long-Term Benefits

    Quitting smoking positively impacts nearly every system in your body, from reducing your risk of life-threatening diseases to improving your daily quality of life.

    General Benefits

    • Financial Savings: You will save a substantial amount of money that can be used for other enjoyable activities.
    • Improved Senses: Your senses of smell and taste will begin to return to normal, making food more enjoyable.
    • Better Appearance: The yellowing of your teeth and nails will stop, your skin will show fewer signs of premature aging/wrinkles, you will have better breath (less odor), and you will no longer smell like cold smoke.
    • Enhanced Social Life: You’ll be free from the hassle of needing to smoke, and you’ll protect your loved ones from secondhand smoke.

    Health and Timeline Benefits

    Your body starts repairing itself within minutes of your last cigarette.

    Specific Benefits for Women

    Women who quit smoking experience specific health benefits:

    • Reproductive Health:
      • Fertility improves, making it easier to conceive.
      • Quitting reduces the risk of premature births, low birth weight babies, and miscarriage.
      • If you’re already pregnant, quitting is the best thing you can do for the health of both you and your baby.
    • Contraceptive pill: it is dangerous to both smoke and take the pill. The associated risks (in particular thrombosis) start to decrease as soon as you quit smoking.
    • Nicotine affects the nervous system of fetuses and infants because it crosses the placental barrier and passes into breast milk.
    • The risk of sudden infant death syndrome is higher when parents smoke.
    • Compared to children of non-smokers, children of smokers are twice as likely to become smokers themselves, and they are also more affected by respiratory infections and asthma..
    • Hormonal Balance: Your estrogen levels gradually return to normal. Smoking can lead to earlier menopause (1–4 years earlier) and more severe menopausal symptoms; quitting helps mitigate this.
    • Cancer Risk: Your risk of cervical cancer drops to near that of a non-smoker within as little as five years.
    • Bone Health: Quitting helps protect against osteoporosis and reduces the risk of fractures.
    • Wrinkles: Sun exposure and smoking are the two main risk factors for wrinkles. By quitting smoking, you can improve the appearance of your skin.

    Specific Benefits for People Aged 65 or Older

    It is never too late to quit. Even long-term smokers who quit in their later years gain significant health advantages, often leading to a longer, more active life.

    • Longevity: Quitting at age 65 can still significantly add years to your life expectancy and improve quality of life. Even quitting at age 80 reduces the risk of dying from smoking-related diseases.
    • Cardiovascular Health: The rapid improvement in circulation and lower risk of heart attack are particularly vital for older adults, whose systems may already be under stress.
    • Cognitive Function: Smoking is a risk factor for dementia and Alzheimer’s disease. Quitting can preserve and improve cognitive function, including memory, attention, and processing speed.
    • Respiratory Function: Improved lung function is crucial for maintaining an active and independent lifestyle. Quitting helps enhance respiratory capacity and reduces the risk of respiratory infections.
    • Medication Efficacy: Smoking can interfere with how some medicines work. Quitting can ensure your medications work more effectively.

    Use the ‘Comments’ field below to share your experience or to suggest improvements to this article.

  • Non-daily and occasional smoking

    Non-daily and occasional smoking

    You often hear about daily smokers, but what about those who only smoke occasionally—maybe a cigarette on the weekend, a few times a month, or even just during a yearly vacation? If you’re a former smoker who sometimes considers “just one puff,” or if you currently identify as a non-daily or occasional smoker, this article is for you.

    Not All Smokers Are Addicted

    It’s true that not every person who smokes is addicted to nicotine. While many non-daily smokers do have some level of dependence, others smoke primarily due to habit, social cues, or psychological triggers (like stress or boredom) without experiencing severe withdrawal symptoms when they stop.

    • Occasional Smokers: These individuals might smoke a few times a month or a year. Their behavior is often tied to specific social situations (e.g., parties, bars) or emotional states.1 They may not feel a strong physical need for nicotine.
    • Non-Daily Smokers: These individuals smoke, but not every day. They might smoke a few cigarettes on the weekend but none during the week. This pattern is often the grey area where dependence is developing or already present, but perhaps not as intense as in a daily smoker.

    However, regardless of the level of addiction, any level of smoking carries risks.

    The Surprising Health Risks of Occasional Smoking

    The idea that “just a few” cigarettes can’t hurt is a dangerous myth. Research shows that non-daily and occasional smoking poses significant health risks.

    • Heart Disease: Occasional smoking significantly increases the risk of heart disease, almost doubling it compared to non-smokers. Even small amounts of smoke can damage blood vessels and increase the risk of blood clots.
    • Lung Cancer: While the risk is lower than for heavy smokers, occasional smokers are still several times more likely to develop lung cancer than people who have never smoked. There is no truly “safe” threshold for cigarette smoke exposure.
    • Other Cancers: Occasional smoking increases the risk of other cancers, including those of the esophagus, stomach, and bladder.
    • Respiratory Issues: Even occasional smoking can impair lung function and increase the risk of respiratory infections.

    The takeaway? When it comes to the toxic substances in tobacco smoke, your body suffers damage with every puff, although the risk increases with the number of cigarettes smoked per day, the frequency, and the duration of smoking.

    The High Risk of Relapse for Former Smokers

    If you have already quit smoking, the biggest threat is the thought that you can handle “just one” cigarette or “just a puff.”

    • Nicotine’s Power: Nicotine is highly effective at re-awakening the dormant addiction pathways in your brain. A single puff is often enough to remind your brain of the “reward” it used to receive.
    • The “Slippery Slope”: That single puff can easily lead to one cigarette the next week, then two the week after, and soon you find yourself back to daily smoking. Relapse rarely happens overnight; it starts with an occasional exception.
    • The Re-Establishment of Triggers: Even an occasional cigarette re-establishes the psychological connection between smoking and your daily life (stress, coffee, alcohol). This makes future cravings much stronger and harder to manage.

    Your Golden Rule: Not Even a Single Puff

    For anyone serious about staying quit, the most important rule is the simplest: You must never take another puff of tobacco.

    This strict policy is your strongest defense against relapse. It eliminates the need for decision-making in a weak moment: the answer is always no.

    If you are currently an occasional smoker who wants to stop before a full addiction takes hold, or a former smoker fighting the urge to try just one, remember: There is no healthy or safe level of smoking.

    Rate this article by clicking on the desired number of stars:
    1 Star2 Stars3 Stars4 Stars5 Stars (1 votes, average: 1.00 out of 5)
    Loading...

    Please use the “Comments” field below to share your experience or suggest improvements to this article.